Article Information
History
- February 4, 2020.
Article Versions
- You are currently viewing Version 1 of this article (February 4, 2020 - 03:06).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Department of Pharmacology, Computational Medicine Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- 2Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA
- 3Columbia University Medical Center, Columbia Center for Translational Tumor Immunology, New York, NY, USA
- ↵*Correspondence to peter_sorger{at}hms.harvard.edu